LIMA1 and cancer: MiR-93-5p has been associated with inhibition of the epithelial protein lost in neoplasm (EPLIN) expression, a protein involved in regulating actin dynamics and cell mobility, thus has been proposed as novel therapeutic factor for inhibiting cancer angiogenesis and progression [69].